Your browser doesn't support javascript.
loading
Safety and efficacy of ruxolitinib in a profoundly thrombocytopenic patient with myelofibrosis.
Armstrong, C; Maung, S W; Neary, P; McHugh, J; Enright, H.
Affiliation
  • Armstrong C; Department of Haematology, Tallaght Hospital, Tallaght, Dublin 24, Ireland.
Ann Hematol ; 94(4): 711-2, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25417831
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Thrombocytopenia / Primary Myelofibrosis / Antineoplastic Agents Limits: Aged / Humans / Male Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2015 Document type: Article Affiliation country: Irlanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Thrombocytopenia / Primary Myelofibrosis / Antineoplastic Agents Limits: Aged / Humans / Male Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2015 Document type: Article Affiliation country: Irlanda